Crystalline lens nuclear age prediction as a new biomarker of nucleus degeneration.

Autor: Guo M; Research Institute of Trustworthy Autonomous Systems, Southern University of Science and Technology, Shenzhen, Guangdong, China.; School of Information Science and Technology, ShanghaiTech University, Shanghai, China., Higashita R; Department of Computer Science and Engineering, Southern University of Science and Technology, Shenzhen, Guangdong, China liuj@sustech.edu.cn lisahigashita@gmail.com ywxu@ieee.org hzfu@ieee.org gaofei@shanghaitech.edu.cn yuanjincornea@126.com.; Tomey Corporation, Nagoya, Aichi, Japan., Lin C; Shenzhen People's Hospital, Shenzhen, Guangdong, China., Hu L; Research Institute of Trustworthy Autonomous Systems, Southern University of Science and Technology, Shenzhen, Guangdong, China., Chen W; Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Sun Yat-Sen University, Guangzhou, Guangdong, China., Li F; Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Sun Yat-Sen University, Guangzhou, Guangdong, China., Lai GWK; Department of Ophthalmology, The University of Hong Kong, Hong Kong, Hong Kong., Nguyen A; Department of Ophthalmology, University of California, San Francisco, California, USA., Sakata R; Department of Ophthalmology, The University of Tokyo, Tokyo, Japan., Okamoto K; Tomey Corporation, Nagoya, Aichi, Japan., Tang B; Research Institute of Trustworthy Autonomous Systems, Southern University of Science and Technology, Shenzhen, Guangdong, China., Xu Y; Intelligent Healthcare Unit, Baidu Inc, Beijing, China liuj@sustech.edu.cn lisahigashita@gmail.com ywxu@ieee.org hzfu@ieee.org gaofei@shanghaitech.edu.cn yuanjincornea@126.com., Fu H; Institute of High Performance Computing, Agency for Science, Technology and Research, Singapore liuj@sustech.edu.cn lisahigashita@gmail.com ywxu@ieee.org hzfu@ieee.org gaofei@shanghaitech.edu.cn yuanjincornea@126.com., Gao F; School of Information Science and Technology, ShanghaiTech University, Shanghai, China liuj@sustech.edu.cn lisahigashita@gmail.com ywxu@ieee.org hzfu@ieee.org gaofei@shanghaitech.edu.cn yuanjincornea@126.com., Aihara M; Department of Ophthalmology, The University of Tokyo, Tokyo, Japan., Zhang X; Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Sun Yat-Sen University, Guangzhou, Guangdong, China., Yuan J; Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Sun Yat-Sen University, Guangzhou, Guangdong, China liuj@sustech.edu.cn lisahigashita@gmail.com ywxu@ieee.org hzfu@ieee.org gaofei@shanghaitech.edu.cn yuanjincornea@126.com., Lin S; Department of Ophthalmology, University of California, San Francisco, California, USA.; Glaucoma Center of San Francisco, San Francisco, California, USA., Leung CK; Department of Ophthalmology, The University of Hong Kong, Hong Kong, Hong Kong.; Department of Ophthalmology and Visual Sciences, The Chinese University, Hong Kong, Hong Kong., Liu J; Research Institute of Trustworthy Autonomous Systems, Southern University of Science and Technology, Shenzhen, Guangdong, China liuj@sustech.edu.cn lisahigashita@gmail.com ywxu@ieee.org hzfu@ieee.org gaofei@shanghaitech.edu.cn yuanjincornea@126.com.; Department of Computer Science and Engineering, Southern University of Science and Technology, Shenzhen, Guangdong, China.; Cixi Institute of Biomedical Engineering, Chinese Academy of Sciences, Cixi, Zhejiang, China.

Publikováno v: The British journal of ophthalmology [Br J Ophthalmol] 2024 Mar 20; Vol. 108 (4), pp. 513-521. Date of Electronic Publication: 2024 Mar 20.

Correction to: Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial.

Autor: Leung CKS; Department of Ophthalmology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, People's Republic of China. cleung21@hku.hk.; Hong Kong Eye Hospital, Hong Kong, People's Republic of China. cleung21@hku.hk.; Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, People's Republic of China. cleung21@hku.hk., Ren ST; Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, People's Republic of China., Chan PPM; Hong Kong Eye Hospital, Hong Kong, People's Republic of China.; Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, People's Republic of China., Wan KHN; Hong Kong Eye Hospital, Hong Kong, People's Republic of China.; Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, People's Republic of China., Kam AKW; Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, People's Republic of China., Lai GWK; Department of Ophthalmology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, People's Republic of China., Chiu VSM; Department of Ophthalmology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, People's Republic of China., Ko MWL; Department of Mechanical Engineering, University of Hong Kong, Hong Kong, People's Republic of China., Yiu CKF; Department of Applied Mathematics, Hong Kong Polytechnic University, Hong Kong, People's Republic of China., Yu MCY; Singapore Eye Research Institute, Singapore, Singapore.

Publikováno v: Trials [Trials] 2022 Feb 10; Vol. 23 (1), pp. 134. Date of Electronic Publication: 2022 Feb 10.